DAWN Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Day One Biopharmaceuticals, Inc.

Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference

a day ago - By: Day One Biopharmaceuticals, Inc.

Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference

23 days ago - By: Day One Biopharmaceuticals, Inc.

Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

a month ago - By: Day One Biopharmaceuticals, Inc.

Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference

a month ago - By: Investor's Business Daily - Mentions: MRSN

Mersana Catapults 200% On Day One Bio's Surprise Buyout

a month ago - By: Benzinga - Mentions: KURA SEE HRMY FOLD ...

Earnings Scheduled For November 4, 2025

4 months ago - By: The Motley Fool

Day One (DAWN) Q2 Revenue Jumps 313%

a month ago - By: Day One Biopharmaceuticals, Inc.

Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference

a month ago - By: Zacks Investment Research

Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 161.36%: Here's is How to Trade

a month ago - By: Stocktwits - Mentions: MRSN

Mersana Therapeutics Stock Explodes Over 200% To Notch Best Day Ever As $285M Buyout Trumps Analyst Downgrades: Retail Cheers ‘Very Good Bargain’

a month ago - By: Benzinga - Mentions: MRSN

Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout

a month ago - By: Stocktwits - Mentions: MRSN

MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal

a month ago - By: Day One Biopharmaceuticals, Inc.

Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases

a month ago - By: Day One Biopharmaceuticals, Inc.

Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases

a month ago - By: Day One Biopharmaceuticals, Inc.

Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

a month ago - By: Zacks Investment Research - Mentions: DNTH

Day One Biopharmaceuticals, Inc. (DAWN) Reports Q3 Loss, Tops Revenue Estimates

a month ago - By: Day One Biopharmaceuticals, Inc.

Day One Reports Third Quarter 2025 Financial Results and Corporate Progress

a month ago - By: Day One Biopharmaceuticals, Inc.

Day One Reports Third Quarter 2025 Financial Results and Corporate Progress

2 months ago - By: Zacks Investment Research

Wall Street Analysts See a 234.66% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High?

2 months ago - By: Day One Biopharmaceuticals, Inc.

Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025

2 months ago - By: Day One Biopharmaceuticals, Inc.

Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025

4 months ago - By: Day One Biopharmaceuticals, Inc.

Day One Reports Second Quarter 2025 Financial Results and Corporate Progress

4 months ago - By: Day One Biopharmaceuticals, Inc.

Day One Reports Second Quarter 2025 Financial Results and Corporate Progress

5 months ago - By: Day One Biopharmaceuticals, Inc.

Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025

5 months ago - By: Day One Biopharmaceuticals, Inc.

Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025

6 months ago - By: Day One Biopharmaceuticals, Inc.

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

6 months ago - By: Day One Biopharmaceuticals, Inc.

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

7 months ago - By: Yahoo Finance - Mentions: DHI CMG

Is Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now?

7 months ago - By: Yahoo Finance - Mentions: VZ NVO LYFT DECK ...

Novo Nordisk A/S (NVO): A Bull Case Theory

7 months ago - By: Yahoo Finance - Mentions: RXRX NVDA PRTA ROG ...

Why Recursion Pharmaceuticals Stock Plummeted 24% This Week

7 months ago - By: Yahoo Finance - Mentions: NVDA GS FCX SCCO ...

DAY ONE BIOPHARMACEUTICALS I (DAWN) Stock News

DAWN Latest News, Press Relases and Analysis

Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference

Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference

Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference

Mersana Catapults 200% On Day One Bio's Surprise Buyout

Earnings Scheduled For November 4, 2025

Day One (DAWN) Q2 Revenue Jumps 313%

Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference

Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 161.36%: Here's is How to Trade

Mersana Therapeutics Stock Explodes Over 200% To Notch Best Day Ever As $285M Buyout Trumps Analyst Downgrades: Retail Cheers ‘Very Good Bargain’

Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout

MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal

Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases

Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases

Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

Day One Biopharmaceuticals, Inc. (DAWN) Reports Q3 Loss, Tops Revenue Estimates

Day One Reports Third Quarter 2025 Financial Results and Corporate Progress

Day One Reports Third Quarter 2025 Financial Results and Corporate Progress

Wall Street Analysts See a 234.66% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High?

Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025

Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025

Day One Reports Second Quarter 2025 Financial Results and Corporate Progress

Day One Reports Second Quarter 2025 Financial Results and Corporate Progress

Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025

Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

Is Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now?

Novo Nordisk A/S (NVO): A Bull Case Theory

Why Recursion Pharmaceuticals Stock Plummeted 24% This Week

NVIDIA Corporation (NVDA): Among Chris Rokos’ Stock Picks with Huge Upside Potential